The U.S. Market for Ethical Nutrition in Healthcare

Home >
Agribusiness >
Food >
Functional Food >
Diet Food >
The U.S. Market for Ethical Nutrition in Healthcare

Report price : $ 4 850
Publication date : June 2007

This report: Profiles and measures the U.S. market for ethical nutrition in healthcare with comprehensive focus on markets for infant and adult enteral and parenteral nutrition and nutritional supplies and equipment; Includes a comparative overview of nutrition and its function in the human body, as well as definitions of products and product types within each market as well ethical nutrition supplies and equipment; Analyzes all market segments with forecasts by sector and sub-sector through 2011; Includes analysis of regulatory issues and industry structure, R&D updates, and patent analysis.

INTRODUCTION STUDY GOALS AND OBJECTIVES REASONS FOR DOING THE STUDY SCOPE AND FORMAT METHODOLOGY AND INFORMATION SOURCES ANALYST CREDENTIALS RELATED BCC REPORTS BCC ONLINE SERVICES DISCLAIMER

SUMMARY

Summary Table:

MARKET FORECAST FOR U.S. ETHICAL NUTRITION PRODUCTS BY CATEGORY, THROUGH 2012 ($ MILLIONS)

Summary Figure:

TOTAL REVENUES OF U.S. ETHICAL NUTRITION PRODUCTS BY CATEGORY AT MANUFACTURERS' SALES LEVELS ($ MILLIONS)

INDUSTRY OVERVIEW DEFINITION OF ETHICAL NUTRITION HUMAN DIGESTION STRUCTURES AND FUNCTIONS OF THE GASTROINTESTINAL SYSTEM Structures and Functions …(Continued) DIGESTION AND ABSORPTION Digestion and Absorption (Continued) Digestion and Absorption (Continued) Digestion and Absorption (Continued) EFFECTS OF AGING NUTRITION

Table 1 ESSENTIAL NUTRIENTS REQUIRED FOR HEALTH

Figure 1 DAILY MEAN ENERGY INTAKE FOR PERSONS AGES 2 MONTHS TO 19 YEARS (%)

MALNUTRITION

TYPES OF SUPPLEMENTAL NUTRITION

Oral Feeding

Tube Feeding

Total Parenteral Nutrition

IMPORTANCE OF THE INDUSTRY

HISTORY OF THE INDUSTRY

INFANT NUTRITION

PEDIATRIC ENTERAL NUTRITION

Table 2 CONTINUOUS VERSUS INTERMITTENT FEEDINGS

ADULT ENTERAL NUTRITION

PARENTERAL NUTRITION

REGULATORY ENVIRONMENT

THE INFANT FORMULA ACT OF 1980

The 1986 Amendments to the Infant Formula Act

REALIGNMENT OF THE CENTER FOR FOOD SAFETY AND APPLIED NUTRITION

SAFETY

COST CONTAINMENT

ADVERTISING

PACKAGING

END-USER ISSUES

DEMOGRAPHICS

Table 3 TOTAL U.S. LIVE BIRTH RATES, 1960-2005 (THOUSANDS)

Figure 2 TOTAL U.S. LIVE BIRTH RATES, 1960-2005 (THOUSANDS)

Table 4 U.S. POPULATION BY SELECTED AGE GROUPS AND BY PERCENT OF TOTAL POPULATION, 2005-2030 (THOUSANDS)

Figure 3 U.S. POPULATION BY SELECTED AGE GROUPS, 2005-2012 (THOUSANDS)

Figure 4 PERCENT U.S. POPULATION BY SELECTED AGE GROUPS, 2005-2012 (%)

FORMULAS WITH DHA AND ARA ADDED

DHA, ARA AND INFANT GROWTH

DHA, ARA and Infant Growth (Continued)

GENETICALLY ENGINEERED PRODUCTS

ENTERAL VS PARENTERAL NUTRITION

INTERNET CAUTIONS

PERCUTANEOUS ENDOSCOPIC GASTROSTOMY

FIBER-BOOSTED FORMULA

FUTURE TRENDS

FUTURE TRENDS (CONTINUED)

INFANT AND PEDIATRIC NUTRITION DEFINITION OF INFANT FORMULA INFANT FORMULA REGULATION GENERAL INGREDIENT SAFETY REQUIREMENTS REQUIREMENTS SPECIFIC TO INFANT FORMULA Requirements Specific …(Continued) BREAST MILK VS. INFANT FORMULA

Table 5 PHASES OF BREAST MILK PRODUCTION

Breast Milk vs. … (continued)

Table 6 NUTRITIONAL COMPARISON OF BREAST MILK AND COMMERCIAL INFANT FORMULAS

Table 6 (CONTINUED)

Table 7 VITAMIN COMPOSITION COMPARISON OF BREAST MILK AND COMMERCIAL INFANT FORMULAS

Table 7 (CONTINUED)

NEW GROWTH CHARTS

FACTORS IMPACTING INFANT FORMULA GROWTH

WIC PROGRAM

WIC Program (Continued)

WIC Contract Bidding

INFANT FORMULA AND LIFE-LONG OBESITY AND DIABETES

MILK-BASED INFANT FORMULA

Product Description

Product Description (Continued)

New Developments

SOY-BASED INFANT FORMULA

Product Description

Product Description (Continued)

DISEASE-SPECIFIC PEDIATRIC FORMULAS

Table 8 CONDITIONS AFFECTING NUTRITION

Table 8 (CONTINUED)

Disease-specific Pediatric … (continued)

Product Description

PEDIATRIC FORMULAS AND SUPPLEMENTS

Product Description

Product Description (Continued)

Table 9 SELECTED PEDIATRIC NUTRITIONAL COMPOSITIONS

Table 9 (CONTINUED)

INFANT AND PEDIATRIC NUTRITION MARKET ANALYSIS

Table 10 MARKET FORECAST FOR U.S. INFANT AND PEDIATRIC NUTRITION PRODUCTS BY CATEGORY, THROUGH 2012 ($ MILLIONS)

Figure 5 MARKET FORECAST FOR U.S. INFANT AND PEDIATRIC NUTRITION PRODUCTS BY CATEGORY, 2005-2012 ($ MILLIONS)

Table 11 MARKET SHARE FOR U.S. INFANT AND PEDIATRIC NUTRITION PRODUCTS BY CATEGORY, 2005-2012 (%)

Figure 6 REVENUE DISTRIBUTION FOR U.S. INFANT AND PEDIATRIC NUTRITION PRODUCTS BY CATEGORY, 2005-2012 (%)

MILK-BASED INFANT FORMULA

Table 12 U.S. MILK-BASED INFANT FORMULA: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)

Figure 7 U.S. MILK-BASED INFANT FORMULA: MANUFACTURERS' MARKET SHARE, 2007 (%)

SOY-BASED INFANT FORMULA

Table 13 U.S. SOY-BASED INFANT FORMULA: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)

Figure 8 U.S. SOY-BASED INFANT FORMULA: MANUFACTURERS' MARKET SHARE, 2007 (%)

SPECIALIZED INFANT FORMULAS AND PEDIATRIC SUPPLEMENTS

Table 14 U.S. SPECIALIZED PEDIATRIC FORMULA: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)

Figure 9 U.S. SPECIALIZED PEDIATRIC FORMULA MANUFACTURERS' MARKET SHARE, 2007 (%)

DISEASE-SPECIFIC INFANT FORMULAS AND PEDIATRIC SUPPLEMENTS

Table 15 U.S. DISEASE-SPECIFIC INFANT FORMULA: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)

Figure 10 U.S. DISEASE-SPECIFIC INFANT FORMULA: MANUFACTURERS' MARKET SHARE, 2007 (%)

ADULT ENTERAL NUTRITION INTRODUCTION ADULT ENTERAL NUTRITION (CONTINUED)

Table 16 ENTERAL FEEDING ROUTES

Table 16 (CONTINUED)

Table 17 ENTERAL FEEDING: ADMINISTRATION METHODS

Table 17 (CONTINUED)

ADULT ENTERAL NUTRITION (CONTINUED)

FACTORS IMPACTING GROWTH

INTACT ADULT ENTERAL FORMULA

PRODUCT DESCRIPTION

NEW DEVELOPMENTS

MODULAR ADULT ENTERAL FORMULA

PRODUCT DESCRIPTION

Product Description (Continued)

DISEASE-SPECIFIC ADULT ENTERAL FORMULA

PRODUCT DESCRIPTION

Product Description (Continued)

ELEMENTAL AND REHYDRATION ADULT ENTERAL FORMULA

PRODUCT DESCRIPTION

ADULT ENTERAL NUTRITION MARKET ANALYSIS

Table 18 MARKET FORECAST FOR U.S. ADULT NUTRITION PRODUCTS BY CATEGORY, THROUGH 2012 ($ MILLIONS)

Figure 11 MARKET FORECAST FOR U.S. ADULT NUTRITION PRODUCTS BY CATEGORY, 2005-2012 ($ MILLIONS)

Table 19 MARKET SHARE OF U.S. ADULT NUTRITION PRODUCTS BY CATEGORY, 2005-2012 (%)

Figure 12 DISTRIBUTION OF REVENUES FROM U.S. ADULT NUTRITION PRODUCTS BY CATEGORY, 2005-2012 (%)

INTACT ADULT ENTERAL NUTRITION

Table 20 U.S. INTACT ADULT ENTERAL NUTRITION: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)

Figure 13 U.S. INTACT ADULT ENTERAL NUTRITION: MANUFACTURERS' MARKET SHARE, 2007 (%)

MODULAR ADULT ENTERAL NUTRITION

Table 21 U.S. MODULAR ADULT ENTERAL: FORMULA MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)

Figure 14 U.S. MODULAR ADULT ENTERAL FORMULA: MANUFACTURERS' MARKET SHARE, 2007 (%)

DISEASE-SPECIFIC ADULT FORMULAS

Disease-specific Adult … (Continued)

Table 22 U.S. DISEASE-SPECIFIC ADULT FORMULA: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)

Figure 15 U.S. DISEASE-SPECIFIC ADULT FORMULA: MANUFACTURERS' MARKET SHARE, 2007 (%)

ELEMENTAL AND REHYDRATION FORMULAS

Table 23 U.S. ELEMENTAL AND REHYDRATION FORMULA: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)

Figure 16 U.S. ELEMENTAL AND REHYDRATION FORMULA: MANUFACTURERS' MARKET SHARE, 2007 (%)

PARENTERAL NUTRITION INTRODUCTION INTRODUCTION (CONTINUED) PHOTODEGRADATION/OXIDATION REACTIONS SORPTION LOSSES HYDROLYSIS REACTIONS COPRECIPITATION FROM DEGRADATION PRODUCTS METABOLIC AND BIOCHEMICAL FACTORS CONTRIBUTING TO VITAMIN DEFICIENCY THIAMINE STATUS IN TPN VITAMIN C OTHER VITAMIN DEFICIENCIES TPN AND CANCER PATIENTS TPN AND CANCER PATIENTS (CONTINUED) FACTORS IMPACTING GROWTH AMINO ACID PARENTERAL FORMULA PRODUCT DESCRIPTION FATS PARENTERAL FORMULA PRODUCT DESCRIPTION DEXTROSE PARENTERAL FORMULA PRODUCT DESCRIPTION MICRONUTRIENT AND MULTIVITAMIN PARENTERAL FORMULAS PRODUCT DESCRIPTION

Table 24 RECOMMENDATIONS FOR PARENTERAL VITAMIN INTAKE

Table 25 RECOMMENDATIONS FOR PARENTERAL MINERAL INTAKE

Table 26 FACTORS THAT INCREASE OR DECREASE ELECTROLYTE NEEDS

PARENTERAL NUTRITION MARKET ANALYSIS

Table 27 MARKET FORECAST FOR U.S. PARENTERAL NUTRITION PRODUCTS, THROUGH 2012 ($ MILLIONS)

Figure 17 MARKET FORECAST FOR U.S. PARENTERAL NUTRITION PRODUCTS BY CATEGORY, 2005-2012 ($ MILLIONS)

Table 28 MARKET SHARE OF U.S. PARENTERAL NUTRITION PRODUCTS BY CATEGORY, 2005-2012 (%)

Figure 18 DISTRIBUTION OF REVENUES FROM U.S. PARENTERAL NUTRITION PRODUCTS BY CATEGORY, 2005-2012 (%)

AMINO ACID PARENTERAL FORMULAS

Table 29 U.S. AMINO ACID PARENTERAL SOLUTION: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)

Figure 19 U.S. AMINO ACID PARENTERAL SOLUTION: MANUFACTURERS' MARKET SHARE, 2007 (%)

FATS PARENTERAL FORMULAS

Table 30 U.S. FATS PARENTERAL FORMULA: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)

Figure 20 U.S. FATS PARENTERAL FORMULA: MANUFACTURERS' MARKET SHARE, 2007 (%)

DEXTROSE PARENTERAL FORMULAS

Table 31 DEXTROSE PARENTERAL FORMULA: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)

Figure 21 DEXTROSE PARENTERAL FORMULA: MANUFACTURERS' MARKET SHARE, 2007 (%)

MICRONUTRIENT AND MULTIVITAMIN PARENTERAL FORMULAS

Table 32 U.S. MICRONUTRIENT AND MULTIVITAMIN PARENTERAL FORMULA: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)

Figure 22 U.S. MICRONUTRIENT AND MULTIVITAMIN PARENTERAL FORMULA: MANUFACTURERS' MARKET SHARE, 2007 (%)

ETHICAL NUTRITION SUPPLIES AND EQUIPMENT INTRODUCTION FACTORS IMPACTING GROWTH FACTORS IMPACTING GROWTH (CONTINUED) ENTERAL SUPPLIES AND EQUIPMENT MARKET PRODUCT DESCRIPTION Product Description (Continued) PARENTERAL SUPPLIES AND EQUIPMENT MARKET PARENTERAL SUPPLIES AND …(CONTINUED) ADMINISTRATION SETS PRODUCT DESCRIPTIONS ETHICAL NUTRITION SUPPLIES AND EQUIPMENT MARKET ANALYSIS

Table 33 MARKET FORECAST FOR U.S. ETHICAL NUTRITION SUPPLIES AND EQUIPMENT, THROUGH 2012 ($ MILLIONS)

Figure 23 MARKET FORECAST FOR U.S. ETHICAL NUTRITION SUPPLIES AND EQUIPMENT, 2005-2012 ($ MILLIONS)

Table 34 MARKET SHARE OF U.S. ETHICAL NUTRITION PRODUCTS BY CATEGORY, 2005-2012 (%)

Figure 24 REVENUE DISTRIBUTION FROM U.S. ETHICAL NUTRITION SUPPLIES AND EQUIPMENT BY CATEGORY, 2005-2012 (%)

ENTERAL DELIVERY SYSTEMS SUPPLIES AND EQUIPMENT

Table 35 U.S. ENTERAL DELIVERY SYSTEM SUPPLIES AND EQUIPMENT: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)

Figure 25 U.S. ENTERAL DELIVERY SYSTEM SUPPLIES AND EQUIPMENT MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 (%)

IV OR PARENTERAL SUPPLIES AND EQUIPMENT

Table 36 U.S. PARENTERAL SUPPLIES AND EQUIPMENT: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)

Figure 26 U.S. PARENTERAL SUPPLIES AND EQUIPMENT: MANUFACTURERS' MARKET SHARE, 2007 (%)

ADMINISTRATION SETS

Table 37 U.S. ADMINISTRATION SET: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)

Figure 27 U.S. ADMINISTRATION SET: MANUFACTURERS' MARKET SHARE, 2007 (%)

TOTAL MARKET SUMMARY

Table 38 MARKET FORECAST FOR U.S. ETHICAL NUTRITION PRODUCTS BY CATEGORY, THROUGH 2012 ($ MILLIONS)

Figure 28 MARKET FORECAST FOR U.S. ETHICAL NUTRITION PRODUCTS BY CATEGORY, 2005-2012 ($ MILLIONS)

TOTAL MARKET PERCENTAGE BY PRODUCT TYPE

Table 39 TOTAL REVENUES, MARKET SHARES, AND NUMBERS OF MANUFACTURERS OF U.S. ETHICAL NUTRITION PRODUCTS BY MARKET SEGMENT, 2007 ($ MILLIONS)

Figure 29 PERCENT SHARES OF U.S. ETHICAL NUTRITION PRODUCTS BY MARKET SEGMENT, 2007 (%)

INDUSTRY PARTICIPANTS BY PRODUCT TYPE

Table 40 ETHICAL NUTRITION INDUSTRY PARTICIPANTS BY PRODUCT CATEGORY, 2006-2007

Table 40 (CONTINUED)

COMPANY PROFILES

ALARIS MEDICAL SYSTEMS, INC. (CARDINAL HEALTH)

BAXTER INTERNATIONAL, INC.

B. BRAUN MELSUNGEN AG

HOSPIRA, INC.

KENDALL HEALTHCARE PRODUCTS

MEAD JOHNSON NUTRITIONAL GROUP

NESTLE USA, INC.

NOVARTIS MEDICAL NUTRITION

ROSS PRODUCTS DIVISION

PBM PRODUCTS, LLC

ZEVEX INTERNATIONAL, INC.

APPENDIX I LIST OF COMPANIES LIST OF COMPANIES (CONTINUED) LIST OF COMPANIES (CONTINUED) LIST OF COMPANIES (CONTINUED) LIST OF COMPANIES (CONTINUED) LIST OF COMPANIES (CONTINUED) LIST OF COMPANIES (CONTINUED)

LIST OF TABLES